239 related articles for article (PubMed ID: 20717180)
1. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM
N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180
[No Abstract] [Full Text] [Related]
2. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
Kawashiri MA; Nohara A; Noguchi T; Tada H; Nakanishi C; Mori M; Konno T; Hayashi K; Fujino N; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
Am J Cardiol; 2012 Feb; 109(3):364-9. PubMed ID: 22112743
[TBL] [Abstract][Full Text] [Related]
4. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
[TBL] [Abstract][Full Text] [Related]
5. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
Mol MJ; Stalenhoef AF
Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
[TBL] [Abstract][Full Text] [Related]
6. [Apheresis in severe hypercholesterolaemia].
Graesdal A; Hovland A; Bjørbaek E
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383
[TBL] [Abstract][Full Text] [Related]
7. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
8. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
[TBL] [Abstract][Full Text] [Related]
9. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia.
Nenseter MS; Bogsrud MP; Græsdal A; Narverud I; Halvorsen B; Ose L; Aukrust P; Holven KB
Thromb Res; 2012 Nov; 130(5):823-5. PubMed ID: 22728023
[No Abstract] [Full Text] [Related]
10. Extracorporeal treatment of hypercholesterolaemia.
Olbricht CJ
Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513
[TBL] [Abstract][Full Text] [Related]
11. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
Saito Y; Shinomiya M; Shirai K; Yoshida S
Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
[No Abstract] [Full Text] [Related]
13. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period].
Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A
Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734
[No Abstract] [Full Text] [Related]
14. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
[TBL] [Abstract][Full Text] [Related]
15. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
16. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
[TBL] [Abstract][Full Text] [Related]
17. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
[TBL] [Abstract][Full Text] [Related]
18. Managing homozygous familial hypercholesterolaemia from cradle to grave.
Thompson GR
Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
[TBL] [Abstract][Full Text] [Related]
19. Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide. Concluding comments.
Catapano AL
Atheroscler Suppl; 2014 Sep; 15(2):52. PubMed ID: 25257077
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
Avis HJ; Hutten BA; Gagné C; Langslet G; McCrindle BW; Wiegman A; Hsia J; Kastelein JJ; Stein EA
J Am Coll Cardiol; 2010 Mar; 55(11):1121-6. PubMed ID: 20223367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
